Skip to main content
Clinical Trials/ITMCTR2000003805
ITMCTR2000003805
Not yet recruiting
未知

A randomized controlled multicenter clinical trial of Xinxinfu combined with Qiangxin Fang in the treatment of coronary heart disease complicated with cardiac insufficiency

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Shanghai Municipal Hospital of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) those who meet the diagnostic criteria of coronary heart disease, chronic heart failure and Yang deficiency and Blood Stasis Syndrome of TCM;
  • (2\) those aged 18 to 75;
  • (3\) those who have not taken any other proprietary Chinese medicine or decoction for treating coronary heart disease with heart failure within 2 weeks;
  • (4\) the patient informed and consented to the study and has signed the informed consent form, in line with our hospital ethics committee certification, all treatment and examination are informed consent of patients or family members.

Exclusion Criteria

  • (1\) with Cardiogenic shock, severe ventricular Arrhythmia, complete atrioventricular block, obstructive cardiomyopathy, severe valvular heart disease, severe pericardial disease;
  • (2\) allergic to or allergic to multiple drugs;
  • (3\) suffering from serious diseases such as liver, kidney, brain, blood system and infection;
  • (4\) non\-cooperative patient or patient with mental disease;
  • (5\) hypertension, diabetes not under control or unstable control;
  • (6\) inability to work with researchers due to disability or mental illness.

Outcomes

Primary Outcomes

Not specified

Similar Trials